| Amber Michele Morse, MD | |
|
1 Childrens Way # 512-16, Little Rock, AR 72202-3500 | |
| (501) 364-1050 | |
| (501) 364-6931 |
| Full Name | Amber Michele Morse |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Emergency Medicine |
| Location | 1 Childrens Way # 512-16, Little Rock, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003133828 | NPI | - | NPPES |
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410229 PECOS PAC ID: 0143134270 Enrollment ID: O20031203000615 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Misfolded proteins associated with Parkinson's disease were detected in cerebrospinal fluid by scientists at McGovern Medical School at The University of Texas Health Science Center at Houston, paving the way to development of a biochemical test to diagnosis the disease.
Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for CF101 in the treatment of psoriasis.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 6 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Misfolded proteins associated with Parkinson's disease were detected in cerebrospinal fluid by scientists at McGovern Medical School at The University of Texas Health Science Center at Houston, paving the way to development of a biochemical test to diagnosis the disease.
Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for CF101 in the treatment of psoriasis.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 6 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Misfolded proteins associated with Parkinson's disease were detected in cerebrospinal fluid by scientists at McGovern Medical School at The University of Texas Health Science Center at Houston, paving the way to development of a biochemical test to diagnosis the disease.
Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for CF101 in the treatment of psoriasis.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 6 days ago
| Entity Name | White River Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134298268 PECOS PAC ID: 0143134270 Enrollment ID: O20070228000056 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Misfolded proteins associated with Parkinson's disease were detected in cerebrospinal fluid by scientists at McGovern Medical School at The University of Texas Health Science Center at Houston, paving the way to development of a biochemical test to diagnosis the disease.
Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for CF101 in the treatment of psoriasis.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber Michele Morse, MD 1 Childrens Way # 653, Little Rock, AR 72202-3500 Ph: (501) 364-1100 | Amber Michele Morse, MD 1 Childrens Way # 512-16, Little Rock, AR 72202-3500 Ph: (501) 364-1050 |
News Archive
Reporting for Kaiser Health News in collaboration with USA Today, Marilyn Werber Serafini writes: "As emotions run high over the law, anger and fear about its impact on Medicare — whether founded or not — could be a deciding factor in some particularly close congressional races, especially in areas where there are large numbers of seniors, say political analysts such as Robert Blendon, professor of health policy and political analysis at the Harvard School of Public Health.
Misfolded proteins associated with Parkinson's disease were detected in cerebrospinal fluid by scientists at McGovern Medical School at The University of Texas Health Science Center at Houston, paving the way to development of a biochemical test to diagnosis the disease.
Significant gaps in how walking capacity and performance is assessed for people with Multiple Sclerosis (MS) could be harming therapy and treatment development according to McGill University researchers.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that are being developed to treat inflammatory diseases, cancer and sexual dysfunction, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for CF101 in the treatment of psoriasis.
A $250,000 grant from the Centers for Disease Control and Prevention (CDC) will support a Rhode Island Hospital research study aimed at reducing the state's leading cause of accidental death among adults. Researchers will explore the use and effectiveness of statewide prescription monitoring programs (PMP) in reducing the number of accidental overdose deaths involving prescription opioids like OxyContin and Vicodin in both Rhode Island and Connecticut.
› Verified 6 days ago
Dustin Edward Williford, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 512-8, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-2963 | |
Kristyn N Jeffries, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 512-1, Little Rock, AR 72202 Phone: 501-364-5262 Fax: 501-364-3418 | |
Indirapriya Darshini Avulakunta, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 512-1, Little Rock, AR 72202 Phone: 501-364-5262 Fax: 501-364-3418 | |
Mohy Morris, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Childrens Way # 512-17, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-3930 | |
Ashley Wilcox Halpain, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 904 Autumn Rd Ste 100, Little Rock, AR 72211 Phone: 501-224-5437 | |
Carl Preston Mccormack, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1001 N University Ave Ste 150, Little Rock, AR 72207 Phone: 501-361-3249 |